Prosecution Insights
Last updated: April 17, 2026
Application No. 18/201,184

MAGNETIC VASCULAR ACCESS GRAFT

Non-Final OA §103§112
Filed
May 24, 2023
Examiner
DEAK, LESLIE R
Art Unit
3799
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
unknown
OA Round
1 (Non-Final)
75%
Grant Probability
Favorable
1-2
OA Rounds
3y 4m
To Grant
93%
With Interview

Examiner Intelligence

Grants 75% — above average
75%
Career Allow Rate
693 granted / 924 resolved
+5.0% vs TC avg
Strong +18% interview lift
Without
With
+18.0%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
43 currently pending
Career history
967
Total Applications
across all art units

Statute-Specific Performance

§101
1.8%
-38.2% vs TC avg
§103
47.9%
+7.9% vs TC avg
§102
25.1%
-14.9% vs TC avg
§112
11.4%
-28.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 924 resolved cases

Office Action

§103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 112 Claim 3 rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 3 recites the limitation "the at least two layers of the flexible substrate" in line 2. There is insufficient antecedent basis for this limitation in the claim. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1-3, 5, 7, 11, 13-16 and 18 are rejected under 35 U.S.C. 103 as being unpatentable over US 9,585,998 to Gage et al in view of US 9,873,000 to Moss et al. PNG media_image1.png 569 647 media_image1.png Greyscale PNG media_image2.png 314 544 media_image2.png Greyscale In the specification and figures, Gage discloses the method substantially as claimed by Applicant. With regard to claims 1-3, 5, 7, 11, 13-16, and 18, Gage discloses a vascular access device deployed in a u-shape curve wherein the device has an arterial end 14 surgically connected to artery 16, and a venous end 24 surgically connected to vein 26, wherein flow runs through the cavity in the tube with cannulation ports 36 and 46 therein. Gage does not disclose a magnet within the cavity. However, Moss discloses a vascular graft 801 that is implanted within a patient, wherein the graft is wrapped with electromagnetic coils 815, 817 or simply a magnetic material or collar 903 that imparts magnetic energy to the blood flowing therein (see Moss FIGS 8, 9, column 5, lines 7-31). Taken together, the references reasonably suggest th PNG media_image3.png 400 528 media_image3.png Greyscale e inclusion of a magnetic graft collar (coils 815, 817) as disclosed by Moss within a vascular graft as disclosed by Gage, wherein the device is implanted within a patient . Allowable Subject Matter Claims 4, 6, 8-11, 17, and 19-20 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. The following is a statement of reasons for the indication of allowable subject matter: The prior art fails to disclose or suggest the combination of elements as claimed by Applicant. With regard to claims 4, 6, 11, the prior art does not disclose or suggest the implantation of the claimed shunt with the arrangement of a spiral configuration with the claimed dimensions. With regard to claims 8-10, 17, 19-20, the prior art fails to disclose or suggest the combination of a magnetized vascular graft in combination with a magnetized vascular graft collar with layers of mesh and silver, copper, or magnetic crystals. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to LESLIE R DEAK whose telephone number is (571)272-4943. The examiner can normally be reached on Monday-Friday, 9am to 5:30pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Brian Casler can be reached on 571-272-4956. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /LESLIE R DEAK/Primary Examiner, Art Unit 3781 16 October 2025
Read full office action

Prosecution Timeline

May 24, 2023
Application Filed
Oct 21, 2025
Non-Final Rejection — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599497
IMPLANTS WITH CONTROLLED DRUG DELIVERY FEATURES AND METHODS OF USING SAME
2y 5m to grant Granted Apr 14, 2026
Patent 12594186
AQUEOUS HUMOR DRAINAGE DEVICE WITH ADJUSTABLE TUBE DIAMETER
2y 5m to grant Granted Apr 07, 2026
Patent 12575972
GLAUCOMA STENT AND METHODS THEREOF FOR GLAUCOMA TREATMENT
2y 5m to grant Granted Mar 17, 2026
Patent 12569604
METHOD AND DEVICES FOR DETERMINING A TIME POINT FOR MEASURING PRESSURE MEASUREMENTS
2y 5m to grant Granted Mar 10, 2026
Patent 12569654
SYSTEMS AND METHODS FOR TREATMENT OF FLUID OVERLOAD
2y 5m to grant Granted Mar 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
75%
Grant Probability
93%
With Interview (+18.0%)
3y 4m
Median Time to Grant
Low
PTA Risk
Based on 924 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in for Full Analysis

Enter your email to receive a magic link. No password needed.

Free tier: 3 strategy analyses per month